This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Joerg Carlsson, MD; Ulrich Tebbe, MD
Detmold, Germany

Arch Intern Med. 1996;156(16):1889-1894.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

We read with great interest the article by Schlicht et al¹ entitled "Physician Practices Regarding Anticoagulation and Cardioversion of Atrial Fibrillation." However, whether the reported data are representative for the United States is unclear, since Schlicht and colleagues' investigation was restricted to 1 hospital and only 55 patients. Other reports about anticoagulation for atrial fibrillation in different clinical settings also indicate a wide discrepancy between the evidence of clinical trials and daily practice,^2,3 with the methological limitations of a survey that probably lead to overestimation of the use of anticoagulation.

Data from a prospective, multicenter cardioversion registry of 61 cardiology clinics⁴ show that anticoagulation for cardioversion and chronic atrial fibrillation is also underused in Germany despite adoption of the guidelines of the American College of Chest Physicians (ACCP) in Europe.⁵ Between July and December 1994, a total of 1152 patients in whom cardioversion of atrial fibrillation . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?